Effect of artificial colloids on blood coagulation during shock stage of severe burn injury

Chinese Medical Journal

Volumn 126, Issue 17, 2013, Pages 3334-3339

  Zhou, Jian Jun ^a   Xing, Nan ^a   Chen, Jiong ^a   Shi, Jian Wu ^a   Su, Guo Liang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Blood coagulation; Burn; Colloid; Hydroxyethyl starch; Shock

Indexed keywords

FIBRINOGEN; GELATIN SUCCINATE; GLUCOSE; HETASTARCH;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; ARTIFICIAL COLLOID; BLOOD CLOTTING; BLOOD SAMPLING; BODY SURFACE; BURN; BURN SHOCK; CLINICAL OBSERVATION; COLLOID; FEMALE; FLUID RESUSCITATION; INTERNATIONAL NORMALIZED RATIO; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PLASMA; PROTHROMBIN TIME; STRESS; SWINE; THROMBOCYTE COUNT;

ANIMALS; BLOOD COAGULATION; BURNS; COLLOIDS; FEMALE; FIBRINOGEN; PARTIAL THROMBOPLASTIN TIME; SHOCK; SWINE;

EID: 84883510970     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20123241     Document Type: Article

References (29)

1. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 2012; 114: 159-169.
2. Chen J, Zheng YS, Han CM, Su GL, Shi JW. Investigation on the hematology parameters of chinese laboratory miniature pig breeds. Chin Ani Husb Veter Med (Chin) 2010; 11: 1877-1879.
3. Xia SC, Chen J, Tang ZJ. Clinical observation of a new hydroxyethyl starch used in resuscitation of burn shock. Chin J Prim Med Pharm (Chin) 2008; 15: 482-483.
4. Coats TJ, Brazil E, Heron M, MacCallum PK. Impairment of coagulation by commonly used resuscitation fluids in human volunteers. Emerg Med J 2006; 23: 846-849.
5. Casutt M, Kristoffy A, Schuepfer G, Spahn DR, Konrad C. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM. Br J Anaesth 2010; 105: 273-281.
6. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) inresuscitation: safety not adequately addressed. Anesth Analg 2011; 112: 635-645.
7. Li XB, Deng SC, Huang X, Zhou JC, Jiang P, Liao DC. The effects of two plasma substitutes on post extracorporeal circulation outcome in infants. Chin J Extracorp Circ (Chin) 2008; 6: 139-141.
8. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008; 107: 382-390.
9. Xia ZF, Wang GY. Discussion on the fluid resuscitation and monitoring during burn shock period. Chin J Burns (Chin) 2008; 24: 241-244.
10. Chen J, Zheng YS, Han CM, Su GL, Shi JW. Application of a new hydroxyethyl starch used in resuscitation of burn shock. Nat Med J China (Chin) 2009; 89: 2726-2728.
11. Piazza O, Scarpati G, Tufano R. Update on transfusion solutions during surgery: Review of hydroxyethyl starches 130/0.4. Int J Gen Med 2010; 3: 287-295.
12. Boks RH, Wijers MJ, Hofland J, Takkenberg JJ, Boqers AJ. Low molecular starch versus gelatin plasma expander during CPB: does it make a difference. Perfusion 2007; 22: 333-337.
13. Chen J. Re-practice and re-cognition of fluid resuscitation for burned patients. J Pract Med 2010; 11: 1869-1871.
14. Hecht-Dolnik M, Barkan H, Taharka A, Luftus J. Hetastarch increases the risk of bleeding complications in patients after off-pump coronary bypass surgery: a randomized clinical trial. J Thorac Cardiovasc Surg 2009; 138: 703-711.
15. Chen J, Han CM, Xia SC, Tang ZJ, Su SJ. Evaluation of effectiveness and safety of a new hydroxyethyl starch used in resuscitation of burn shock. Chin J Burns (Chin) 2006; 22: 333-336.
16. Shi JW, Chen J, Zhou JJ, Su GL, Zheng YS. A role for long chain myosin light chain kinase in microvascular hyperpermeability during severe burns. Chin J Surg (Chin) 2010; 48: 1194-1195.
17. Guo ZR. Yang ZC. Fluid resuscitation during the shock stage of mass burn patients. Chinese medicine of burns, 1st ed. Beijing: People Hygiene Press; 2008: 21-35.
18. Yang SL, Ren HY, Wang H, Feng ST, Gan SX, Wang AD, et al. Investigation on the hematology parameters of chinese laboratory miniature pig breeds. Chin Ani Husb Veter Med (Chin) 2007; 34: 38-41.
19. Wang AD, Guo YF, Li B, Hu CH, Wei H. Determination of some haemal physiological parameters in Ba-Ma mini-pig. Shanghai Lab Anim Sci (Chin) 2001; 21: 75-78.
20. Grottke O, Braunschweig T, Henzler D, Coburn M, Tolba R, Rossaint R. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 2010; 14: R62.
21. Kehrel BE. Platelets: biochemistry and physiology. Hamostaseologie 2008; 28: 289-298.
22. Park MS, Salinas J, Wade CE, Wang J, Martini W, Pusateri AE, et al. Combining early coagulation and inflammatory status improves prediction of mortality in burned and non burned trauma patients. J Trauma 2008; 64: S188-S194.
23. Asakura H. Interpretation of hemostatic and fibrinolytic markers. Rinsho Byori 2011; 59: 970-977.
24. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation 2010; 121: 2550-2556.
25. Douglas AD, Jefferis J, Sharma R, Parker R, Handa A, Chantler J. Evaluation of point-of-care activated partial thromboplastin time testing bycomparison to laboratory-based assay for control of intravenous heparin. Angiology 2009; 60: 358-361.
26. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Kukkonen SI, Niemi TT. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial. Anesth Analg 2009; 108: 30-36.
27. Mosesson MW. Fibrinogen and fibrin structure and functions. J Thromb Haemost 2005; 3: 1894-1904.
28. Fang DY, Li ZH, Zhao CQ. The expression and clinical significance of plasma d-dimer and fibrinogen in patients with severe burn. Chin J Misdiag Sci (Chin) 2008; 8: 563-564.
29. Schaden E, Hoerburger D, Hacker S, Kraincuk P, Baron DM, Kozek-Langenecker S. Fibrinogen function after severe burn injury. Burns 2012; 38: 77-82.